Income statement
USD
Annual
| Metric | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|
| Revenue | 103M | 171M | 172M | 208M | 225M |
| Gross Profit | 46M | 101M | 90M | 104M | 113M |
| Operating Income | 477K | 12M | -206K | -8M | 8M |
| EBITDA | 2M | 13M | 3M | -5M | 12M |
| Net Income | -880K | 10M | 582K | -7M | 2M |
| EPS (Diluted) | — | — | — | — | — |
Consumer Defensive
Live Price
Offline$0.01
+0.00% today
1Y Change
+4900.00%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 252 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tigrent Inc. (TIGE) is a Consumer Defensive stock with listed on OTC. The stock last traded around $0.01 and up 4900.0% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of -40.0%, EPS growth of -108.1%, a dividend yield of 0.0%. What stands out right now is revenue -40.0%, EPS -108.1%, free cash flow +51.0% with operating margin 0.5% and ROIC 2.2%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TIGE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TIGE
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TIGE Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TIGE and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$224.7M
+8.2% YoY
FY Net Income
$2.3M
+134.7% YoY
Free Cash Flow
$11.2M
+1895.3% YoY
Revenue Growth
-40.0%
EPS Growth
-108.1%
Gross Margin
44.5%
Net Margin
-0.9%
Income statement
USD
| Metric | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|
| Revenue | 103M | 171M | 172M | 208M | 225M |
| Gross Profit | 46M | 101M | 90M | 104M | 113M |
| Operating Income | 477K | 12M | -206K | -8M | 8M |
| EBITDA | 2M | 13M | 3M | -5M | 12M |
| Net Income | -880K | 10M | 582K | -7M | 2M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4M | 11M | 24M | 33M | 33M |
| Total Assets | 34M | 54M | 82M | 92M | 92M |
| Total Liabilities | 78M | 99M | 134M | 147M | 141M |
| Shareholder Equity | -44M | -44M | -53M | -55M | -49M |
| Total Debt | 1M | 6M | 3M | 3M | 6M |
| Net Debt | -3M | -5M | -21M | -30M | -27M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
19M
+1483.8% YoY
Capital Expenditures
8M
-330.2% YoY
Free Cash Flow
11M
+1895.3% YoY
Key ratios
Gross Margin
44.5%
Operating Margin
0.5%
Net Margin
-0.9%
ROE
2.0%
Debt / Equity
-0.02x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.